Association of HLA-B*5701 Genotypes and Abacavir-Induced Hypersensitivity Reaction: A Systematic Review and Meta-Analysis

Authors

  • Wimonchat Tangamornsuksan Center of Excellence for Environmental Health & Toxicology; Pharmacokinetic Research Unit; Department of Pharmacy Practice;
  • Ornrat Lohitnavy Center of Excellence for Environmental Health & Toxicology; Pharmacokinetic Research Unit; Department of Pharmacy Practice;
  • Chuenjid Kongkaew Center of Excellence for Environmental Health & Toxicology; Department of Pharmacy Practice;
  • Nathorn Chaiyakunapruk Center of Excellence for Environmental Health & Toxicology; Pharmacokinetic Research Unit; Center of Pharmaceutical Outcomes Research, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand; School of Pharmacy, Monash University Malaysia, Malaysia; School of Pharmacy, University of Wisconsin, Madison, USA; School of Population Health, University of Queensland, Brisbane, Australia;
  • Brad Reisfeld Center of Excellence for Environmental Health & Toxicology; Pharmacokinetic Research Unit; Department of Pharmacy Practice; Department of Chemical and Biological Engineering, Colorado State University, Fort Collins, CO, USA.
  • Norman Charles Scholfield Center of Excellence for Environmental Health & Toxicology; Pharmacokinetic Research Unit; Department of Pharmacy Practice;
  • Manupat Lohitnavy Center of Excellence for Environmental Health & Toxicology; Pharmacokinetic Research Unit; Department of Pharmacy Practice;

DOI:

https://doi.org/10.18433/J39S3T

Abstract

OBJECTIVES: This study aimed to systematically review and quantitatively synthesize the association between HLA-B*5701 and abacavir-induced hypersensitivity reaction (ABC-HSR). METHODS: We searched for studies that investigated the association between HLA-B genotype and ABC-HSR and provided information about the frequency of carriers of HLA-B genotypes among cases and controls. We then performed a meta-analysis with a random-effects model to pool the data and to investigate the sources of heterogeneity. RESULTS: From 1,026 articles identified, ten studies were included. Five using clinical manifestation as their diagnostic criteria, 409 and 1,883 subjects were included as cases and controls. Overall OR was 23.6 (95% CI = 15.4 – 36.3). Whereas, the another five studies using confirmed immunologic test as their diagnostic criteria, 110 and 1,968 subjects were included as cases and controls, respectively. The association of ABC-HSR was strong in this populations with HLA-B*5701. Overall OR was 1,056.2 (95% CI = 345.0 – 3,233.3). CONCLUSIONS: Using meta-analysis technique, the association between HLA-B*5701 and ABC-HSR is strong in the studies using immunologic confirmation to identify ABC-HSR. These results support the US FDA recommendations for screening HLA-B*5701 allele before initiating abacavir therapy.

This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.

Downloads

Download data is not yet available.

Downloads

Published

2015-02-15

How to Cite

Tangamornsuksan, W., Lohitnavy, O., Kongkaew, C., Chaiyakunapruk, N., Reisfeld, B., Scholfield, N. C., & Lohitnavy, M. (2015). Association of HLA-B*5701 Genotypes and Abacavir-Induced Hypersensitivity Reaction: A Systematic Review and Meta-Analysis. Journal of Pharmacy & Pharmaceutical Sciences, 18(1), 68–76. https://doi.org/10.18433/J39S3T

Issue

Section

Review Articles